This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2024 Feb 15;390(7):584-586.

doi: 10.1056/NEJMp2400209. Epub 2024 Jan 24.

Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy

Nicole Verdun¹, Peter Marks¹

Affiliations

PMID: 38265704
DOI: 10.1056/NEJMp2400209

Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy

Nicole Verdun et al. N Engl J Med. 2024.

. 2024 Feb 15;390(7):584-586.

doi: 10.1056/NEJMp2400209. Epub 2024 Jan 24.

Authors

Nicole Verdun¹, Peter Marks¹

Affiliation

¹ From the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

PMID: 38265704
DOI: 10.1056/NEJMp2400209

No abstract available

PubMed Disclaimer

Comment in

T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era.
Dores GM, Morton LM. Dores GM, et al. N Engl J Med. 2024 Aug 15;391(7):662-664. doi: 10.1056/NEJMc2408029. N Engl J Med. 2024. PMID: 39141862 Free PMC article. No abstract available.

References

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database